Selecting the Right Test Just Got Easier: Connective Tissue Disorder Panels Expanded
We are pleased to announce that our Marfan Syndrome & Aortopathies Panel and our Ehlers-Danlos syndromes panels have been expanded to include a wider clinical spectrum.
Each of our PhD experts each focuses on a specific subset of the genome. As new publications become available, we curate our gene lists and rise to the challenge to keep our test menu current. In light of some new publications and at the request of expert clinicians, we have recently expanded a few of our connective tissue disorder panels. Our goal is to make it easy to select the right test for your patients.
Employee Spotlight: Dr. Steiner named Editor in Chief of Genetics in Medicine
PreventionGenetics’ Chief Medical Officer, Dr. Robert Steiner, MD, FAAP, FACMG, has been named Editor in Chief of Genetics in Medicine (GIM) to succeed James P. Evans, MD, PhD, FACMG. Genetics in Medicine is the American College of Medical Genetics and Genomics’ monthly peer-reviewed journal. Dr. Steiner has been involved with GIM since 2000, when he began reviewing for the journal. Since 2004, Dr. Steiner has authored or coauthored various publications in the journal and was asked to serve as Biochemical Genetics Editor in 2006. In 2011, he became deputy editor of the journal.
Employee Spotlight: MDA Summer Camp
A proud supporter of the Muscular Dystrophy Association, PreventionGenetics sponsored an employee to volunteer at MDA Summer Camp. MDA Summer Camp is a weeklong camp held across the United States designed for kids diagnosed with muscular dystrophy and related diseases. Campers are able to participate in a variety of camp activities including zip lining, swimming, paintball, bonfires, fishing, mini golf, a carnival, and much more! MDA Summer Camp provides campers with an opportunity to gain independence and fosters lifelong friendships with fellow campers at no cost to the families.
Updated Kidney Panels
As a leading provider of genetic testing for inherited kidney disorders, we are pleased to announce updates to three Polycystic Kidney Disease testing panels, Hereditary Cystic Kidney Diseases, Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) panel, and our Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) panel. The updates involve adding new genes and copy number variant (CNV) detection via sequencing to increase clinical sensitivity.
Early diagnosis of kidney disease is important for establishing optimal maintenance and treatment plans. This is why, at PreventionGenetics, we’re constantly striving to provide the best genetic tests.
New Features and Benefits of PGxomeⓇ Custom Panels
PGxome Custom Panels are PreventionGenetics’ whole exome-based sequencing panels that are fully customizable to fit your patients’ personalized needs. Any subset of nearly 5,000 clinically relevant genes on our test menu may be chosen. Reduced pricing, added features, and flexible test building options enhance quality and value for you and your patients. The innovative approach of PGxome Custom Panels provides a new level of flexibility in genetic testing.